Global EditionASIA 中文双语Français
China
Home / China / Top News

China will surely win anti-COVID war in Shanghai, with time-tested epidemic control policy: top leadership

Xinhua | Updated: 2022-05-05 21:06
Share
Share - WeChat

BEIJING - China will surely win the war against COVID-19 with its scientific and effective epidemic control policy that will stand the test of time, according to a meeting of the top leadership on Thursday.

The meeting of the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee was chaired by Xi Jinping, general secretary of the CPC Central Committee.

The meeting analyzed the current epidemic prevention and control situation, studied priorities and made arrangements for relevant work.

The meeting said China has since March withstood the most challenging COVID-19 control test since the anti-epidemic battle of Wuhan, and has secured progress with nationwide concerted efforts.

As the pandemic is still raging across the world and the coronavirus keeps mutating, there is a great deal of uncertainty concerning how the pandemic will develop, according to the meeting, which warned against any slackening in the control efforts.

"Relaxation will undoubtedly lead to massive numbers of infections, critical cases and deaths, seriously impacting economic and social development and people's lives and health," the meeting said.

The meeting stressed the importance of unswervingly adhering to the dynamic zero-COVID policy and resolutely fighting any attempts to distort, question or dismiss China's anti-COVID policy.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US